Screener
Change in fair value of derivative liabilities
ImmunityBio, Inc.·Business Segments·1 segment·Rolls up to Derivative, Gain (Loss) on Derivative, Net
Breakdown
Segments
Reportable SegmentView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|
| Reportable Segment | $5.58M | $1.93M | $289K | $1.11M |
| Total | $5.58M | $1.93M | $289K | $1.11M |